(Q37276379)

19 August 2017

1 reference

title

Monitoring the tobacco use epidemic I. Overview: Optimizing measurement to facilitate change (English)

1 reference

19 August 2017

1 reference

Gary A Giovino

1

1 reference

19 August 2017

Lois Biener

2

1 reference

19 August 2017

Anne M Hartman

3

1 reference

19 August 2017

Stephen E Marcus

4

1 reference

19 August 2017

Michael W Schooley

5

1 reference

19 August 2017

Terry F Pechacek

6

1 reference

19 August 2017

Donna Vallone

7

1 reference

19 August 2017

language of work or name

English

0 references

publication date

9 September 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

48

1 reference

19 August 2017

issue

1 Suppl

1 reference

19 August 2017

page(s)

S4-10

1 reference

The theory of planned behavior

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

Research priorities for tobacco control in developing countries: a regional approach to a global consultative process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

The role of sensory perception in the development and targeting of tobacco products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

Monitoring the tobacco use epidemic IV. The vector: Tobacco industry data sources and recommendations for research and evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

Marketing to America's youth: evidence from corporate documents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

Monitoring the tobacco use epidemic III: The host: data sources and methodological challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

Smoking and carcinoma of the lung; preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

A study of the aetiology of carcinoma of the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

Pharmacokinetics and pharmacodynamics of moist snuff in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

Monitoring the tobacco use epidemic V: The environment: factors that influence tobacco use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

Understanding environmental, situational and intrapersonal risk and protective factors for youth tobacco use: the Theory of Triadic Influence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

The conceptual framework of the International Tobacco Control (ITC) Policy Evaluation Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

Epidemiology of tobacco use in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

Methods to assess potential reduced exposure products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

Cancer and tobacco smoking; a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

The best practices: use of the guidelines by ten state tobacco control programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

National Institutes of Health State-of-the-Science conference statement: tobacco use: prevention, cessation, and control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

How did UK cigarette makers reduce tar to 10 mg or less?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

Surveillance of smokeless tobacco nicotine, pH, moisture, and unprotonated nicotine content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

Monitoring the tobacco use epidemic II: The agent: Current and emerging tobacco products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

The American Stop Smoking Intervention Study. Conceptual framework and evaluation design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

Evaluation of the American Stop Smoking Intervention Study (ASSIST): a report of outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

Improving the measurement and use of tobacco control "inputs".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

Patterns of global tobacco use in young people and implications for future chronic disease burden in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

Brand differences of free-base nicotine delivery in cigarette smoke: the view of the tobacco industry documents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

The precaution adoption process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

inferred from DOI database lookup

7 January 2021

based on heuristic

A model of the precaution adoption process: Evidence from home radon testing

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.08.007

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YPMED.2008.08.007

1 reference

19 August 2017

1 reference